You are on page 1of 4

Original/Brief

Formulation and evaluation of transparent


ibuprofen soft gelatin capsule
A. Lodha, A. Patel, J. Chaudhuri, P. Jadia, T. Joshi, J. Dalal

Gujarat Liqui Pharmacaps ABSTRACT


Pvt. Ltd. 662-666, GIDC,
The compound ibuprofen, 2-(4-isobutylphenyl) propionic acid, has been known e.g. from Martindale, the Extra
Waghodia, Baroda,
Gujarart, India
Pharmacopoeia, 28th edition, 1982, p.256, as a drug which had anti-inflammatory and analgesic properties. It is
used for the treatment of rheumatoid arthritis or other inflammatory diseases of joints, soft tissue rheumatism
Address for correspondence: and gout. Ibuprofen, because of its analgesic properties, has been widely used as anodyne, e.g. against pain
Lodha Ami, or discomfort associated with headache, toothache or menstruation.
E-mail: ami.m.sha@gmail.
A medication suitable to combat acute pain is demanded to display its effects fast which action, in turn, is only
com
achieved by a quick release and good bio-availability of the active-ingredient. It is for the commercial forms
in particular that the conditions of preparation must be strictly observed, as minor alterations in production
procedures such as mixing, pressure of compression and type of machine will affect the physical properties of
the particles of he active ingredient and will deteriorate its bio-availability. It is an object of this presentation
to provide a medicament that can be readily taken that contains an active amount of ibuprofen in a carrier,
that is simple to prepare and that will quickly display a high activity.

KEY WORDS: Ibuprofen, anti-inflammatory

Formulation development 300) in the fill formulations is limited due to their ability to
diffuse into the shell and thereby act as gelatin plasticizers. The
Vehicle extent of diffusion of a polyethylene glycol from the fill into the
shell decreases with an increase in its molecular weight. Orally

C ompound that show low aqueous bio-availability have the


tendency to precipitate when small amounts of water is
added to the solution, thus affecting its resorption. This can
administered polyethylene glycols of a lower molecular weight
(e.g., PEG 200, PEG 300, PEG 400) are well absorbed in the
GIT and are mostly (>90%) excreted unchanged in urine and
be overcome by the addition of combination of Hydrophilic feces in human subjects.
vehicles. Hydrophilic vehicles for softgel fill formulations
include polyethylene glycols (e.g., PEG 400, PEG 600), Solubility enhancers
polyoxyethylene – polyoxypropylene copolymers (Poloxamers),
propylene glycol, glycerin, ethyl alcohol, and water. The use of It is desirable to produce a highly concentrated solution of a
propylene glycol, glycerin, and water is restricted to less than compound as it allows the encapsulation of a unit dose of the
10% of the total fill formulation, as these vehicles can also compound in a softgel that is small enough to swallow easily
act as plasticizers for the gelatin shell. Similarly, use of lower and thus improving patient acceptance of the medication.
molecular weight polyethylene glycols (e.g., PEG 200, PEG The solubility of the acidic compounds like ibuprofen can be
enhanced in polyethylene glycols by 40–400% through partial
Access this article online ionization of this compound with a hydroxide ion species
Quick Response Code: (e.g., sodium hydroxide, potassium hydroxide, ammonium
Website: hydroxide). When this neutralization (counter ion) technique
www.jpbsonline.org is used to obtain a highly concentrated solution of a compound,
it is essential to keep the apparent pH of the final fill
DOI: formulation at least between 2.5 and 7.5. At pH values below
10.4103/0975-7406.94154 2.5, gelatin is hydrolyzed causing leakage of the softgel, whereas
at pH values above 7.5, gelatin may be either hydrolyzed or

How to cite this article: Lodha A, Patel A, Chaudhuri J, Jadia P, Joshi T, Dalal J. Formulation and evaluation of transparent ibuprofen soft gelatin capsule. J
Pharm Bioall Sci 2012;4:95-7.

Journal of Pharmacy and Bioallied Sciences March 2012 Supplement S95 


 Patel et al.: Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule

tanned (i.e. cross-linked) resulting in decreased solubility of the procedure with another 19 capsules. The weight complies
the gelatin shell. as per the pharmacopoeial limits.

Alternately, the solubility of ibuprofen in hydrophilic Loss on drying of the capsule shell
vehicles can also be improved significantly by using povidone
(polyvinylpyrrolidone, PVP) as a solubility enhancer. Unlike the Soft gelatin capsule shells normally contain 6% to 13% of water
solubility enhancing techniques employed the use of povidone and the Loss on Drying of the shell was found to be within the
as a solubility enhancer results in a softgel fill formulation limit.
containing a compound in its original form that is very
compatible with the other softgel components. In addition, as Disintegration test for soft gelatin capsules
povidone is available in a variety of molecular weights ranging
from 2500 to 3000000 the viscosity of a fill formulation can
be controlled through the selection of appropriate molecular
weight and concentration of the polymer without adversely
affecting the solubility of dissolved compounds.

Materials and Methods

Ibuprofen (active ingredient), polyethylene glycol 400


(vehicle), polyvinyl pyrrolidone (K-10) (solubility enhancer), Although there are no official limits specified, ideally a
polyethylene glycol (co-solvent), potassium hydroxide
disintegration time within 30 minutes is considered ideal for soft
(ionizing agent).
gelatin capsules. The formulated capsules disintegrated within
a maximum of about 25 mins as shown in the table.
Optimization of fill material
Dissolution studies of ibuprofen soft gelatin
In order to obtain the optimized fill formulation, ibuprofen is
initially dissolved in 15 to 50 parts of polyethylene glycol along
Ideal media for dissolution study was optimized from the
with 2 to 50 parts of polyethylene glycol which is then mixed
disintegration test prior to dissolution testing studies. Various
with polyvinyl pyrrolidone K-30. The previously mixed potassium
Gastric stimulated media for dissolution were 0.1N HCl (pH 1-2),
hydroxide with water is added till optimum pH is obtained.
acetate buffer (pH 4.5), phosphate buffer (pH 7.8) and water.
The dissolution media consisting of Phosphate Buffer Solution at
Encapsulation parameter
pH 7.8 provided best cumulative drug release as depicted in
graphs.

Assay

Experimental chromatographic conditions


Stationary phase: Phenomex, 5 µm, C18 (250x4.6 mm) column
Mobile phase: A mixture of 3 volumes of orthophosphoric acid,
247 volumes of water and 750 volumes of methanol
Detection wavelength: 264 nm
Flow rate: 1.5 ml/minute
Operating pressure: 160 kgf
Temperature: Room temperature.

Preparation of standard solution:


100 mg of Ibuprofen diluted with the Mobile phase up to 100 ml
(Stock Solution).
Evaluation of ibuprofen soft gelatin capsules Make 100 µg/ml of Ibuprofen diluted with the Mobile phase.
Aliquots of standard solutions containing 40  µg/ml of
Uniformity of fill weight of the capsules Ibuprofen.

Weigh an intact capsule. Open it without losing any part of the Preparation of sample solution:
shell and remove the contents as completely as possible. Wash 20 tablets → Average weight → Powdered and weighed a
the shell with a suitable solvent and keep aside until the odor of quantity equivalent to 100 mg of Ibuprofen were transferred
the solvent is not perceptible. Weigh the shell. The difference to 100 ml standard flask and make up with mobile phase. Filter
between the weighing gives the weight of the contents. Repeat with Whatman filter paper.

 S96 Journal of Pharmacy and Bioallied Sciences March 2012 Supplement


Patel et al.: Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule 

Figure 2: Comparative dissolution studies of developed formula and


Figure 1: Optimization of dissolution media marketed product

Aliquots of solution containing 40µg/ml diluted with mobile by employing the above mentioned techniques, a high-
phase. bioavailability is achieved with a high degree of reliability
and reproducibility and hence, a fast and reliable display of
Analysis of formulation its effects.

References
1. Brox W. 1988. Soft gelatin capsules and methods for their production.
US Patent 4,744,988.
*RSD of six observations 2. Brox W. 1988. Gelatin capsule. US Patent 4,780,316.
3. Nazzal S, Wang Y. 2001. Characterization of soft gelatin capsules by
Conclusion thermal analysis. Int J Pharm 230:35–45.
4. Dhabhar DJ. 1996. Process for reducing the precipitation of difficulty
soluble pharmaceutical actives US Patent 5,484,606.
The soft gelatin dosage form has an advantage over all other
previously known dosage form for ibuprofen that upon Source of Support: Nil, Conflict of Interest: None declared.
intake the active ingredient is quickly resorbed. Nevertheless,

Journal of Pharmacy and Bioallied Sciences March 2012 Supplement S97 


Copyright of Journal of Pharmacy & Bioallied Sciences is the property of Medknow Publications & Media Pvt.
Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright
holder's express written permission. However, users may print, download, or email articles for individual use.

You might also like